THE PROSTATE CANCER FOUNDATION and the U.S Department of Veterans Affairs will collaborate on a $50 million precision medicine initiative aimed at expanding prostate cancer clinical research among veterans and speed the development of new treatment options and cures for prostate cancer patients. The PCF-VA agreement was signed as part of Launch Pad: Pathways to...
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
